HENNIGSDORF
Germany
93
2026-02-26
64
2025-10-14
These are the the leading inventors for applications assigned to B.R.A.H.M.S GMBH:
B.R.A.H.M.S GMBH based in HENNIGSDORF, DE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Pro-ADM for Prognosis of Trauma-Related Complications in Polytrauma
#2 | 2025-12-04PRESCRIPTION OF REMOTE PATIENT MANAGEMENT BASED ON BIOMARKERS
#3 | 2025-10-23BIOMARKERS FOR THE PREDICTION OF PRETERM BIRTH
#4 | 2025-06-12SAMPLE INCLUDING PRO-ADM AS A THERAPY MONITORING MARKER FOR CRITCALLY ILL PATIENTS
#5 | 2025-01-30BIOMARKERS FOR PROGNOSIS OF EARLY ONSET PREECLAMPSIA
#6 | 2024-11-28ANTIBIOTIC THERAPY GUIDANCE BASED ON PROCALCITONIN IN PATIENTS WITH COMORBIDITIES
#7 | 2023-06-08BIOMARKERS FOR THE DIAGNOSIS OF RESPIRATORY TRACT INFECTIONS
#8 | 2023-05-25PRO-ADRENOMEDULLIN FOR PROGNOSING DISEASE PROGRESSION IN SEVERE ACUTE RESPIRATORY SYNDROME (SARS)
#9 | 2022-08-18 β Patent 12,442,825 granted on 2025-10-14PRESCRIPTION OF REMOTE PATIENT MANAGEMENT BASED ON BIOMARKERS
#10 | 2022-07-21 β Patent 12,000,845 granted on 2024-06-04Method for discharging a patient from an intensive care unit
#11 | 2022-07-14 β Patent 12,405,279 granted on 2025-09-02METHOD FOR PREPARING A SAMPLE
#12 | 2021-12-30 β Patent 12,560,620 granted on 2026-02-24Pro-ADM for Prognosis of Trauma-Related Complications in Polytrauma Patients
#13 | 2021-11-11 β Patent 12,181,474 granted on 2024-12-31Biomarkers for the diagnosis of invasive fungal infections
#14 | 2021-09-23PRO-ADM FOR PROGNOSING THE RISK OF A MEDICAL CONDITION REQUIRING HOSPITALIZATION IN PATIENTS WITH SYMPTOMS OF INFECTIOUS DISEASE
#15 | 2021-04-15ANTIBIOTIC THERAPY GUIDANCE BASED ON PRO-ADM
#16 | 2021-04-15 β Patent 12,265,092 granted on 2025-04-01Workflow for risk assessment and patient management using procalcitonin and midregional-proadrenomedullin
#17 | 2020-11-26 β Patent 11,592,450 granted on 2023-02-28Diagnosis and risk stratification of fungal infections
#18 | 2020-10-08 β Patent 12,153,057 granted on 2024-11-26Antibiotic therapy guidance based on procalcitonin in patients with comorbidities
#19 | 2020-09-24PRO-ADM AS A THERAPY MONITORING MARKER FOR CRITCALLY ILL PATIENTS
#20 | 2020-08-27 β Patent 11,327,082 granted on 2022-05-10Proadrenomedullin as a marker for abnormal platelet levels
#21 | 2020-08-27 β Patent 12,517,138 granted on 2026-01-06METHOD FOR GUIDANCE OF FLUID THERAPY BASED ON PROADRENOMEDULLIN
#22 | 2020-08-20PCT AND PRO-ADM AS MARKERS FOR MONITORING ANTIBIOTIC TREATMENT
#23 | 2020-07-16 β Patent 12,385,926 granted on 2025-08-12MMP-8 AS A MARKER FOR IDENTIFYING INFECTIOUS DISEASE
#24 | 2020-03-12 β Patent 11,041,867 granted on 2021-06-22ProADM and/or histones as markers indicating an adverse event
#25 | 2019-12-05 β Patent 10,857,129 granted on 2020-12-08Vreceptor antagonist for use in the treatment of patients having an elevated AVP level and/or an elevated copeptin level
#26 | 2019-07-25 β Patent 11,835,531 granted on 2023-12-05Procalcitonin for the prognosis of adverse events
#27 | 2018-09-06 β Patent 10,954,298 granted on 2021-03-23Method of obtaining a binder to prepro-vasopressin or fragments thereof
#28 | 2018-05-24DETERMINATION OF A MIDREGIONAL PROADRENOMEDULLIN PARTIAL PEPTIDE IN BIOLOGICAL FLUIDS FOR DIAGNOSTIC PURPOSES, AND IMMUNOASSAYS FOR CARRYING OUT SUCH A DETERMINATION
#29 | 2017-12-28 β Patent 11,402,393 granted on 2022-08-02Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with non-specific complaints
#30 | 2017-12-28PROGNOSIS OF ADVERSE EVENTS IN PATIENTS WITH SUSPECTED CHRONIC HEART FAILURE
#31 | 2017-08-24DIAGNOSTIC METHOD FOR DISORDERS USING COPEPTIN
#32 | 2017-05-11 β Patent 10,048,280 granted on 2018-08-14Immunoassay for the detection of procalcitonin
#33 | 2016-11-03 β Patent 9,753,039 granted on 2017-09-05Prognosis of adverse events in patients with suspected chronic heart failure
#34 | 2016-06-09DIAGNOSIS AND RISK STRATIFICATION USING NT-proET-1
#35 | 2016-05-26 β Patent 10,024,872 granted on 2018-07-17Augurin immunoassay
#36 | 2016-05-12 β Patent 9,513,301 granted on 2016-12-06Method for risk stratification in stable coronary artery disease
#37 | 2016-05-12 β Patent 10,254,289 granted on 2019-04-09In vitro method for early or differential diagnosis or prognosis of myocardial infarction in a patient
#38 | 2016-04-07 β Patent 10,921,330 granted on 2021-02-16Method for diagnosis of dementias and neuroinflammatory diseases based on an increased level of procalcitonin in cerebrospinal fluid
#39 | 2015-10-15 β Patent 9,952,229 granted on 2018-04-24Arginine vasopressin pro-hormone as predictive biomarker for diabetes
#40 | 2015-09-03 β Patent 9,810,699 granted on 2017-11-07Risk assessment for antibiotics treatment in patients suffering from primary non-infectious disease by determining the level of procalcitonin
#41 | 2015-07-09METHODS OF DIAGNOSIS AND RISK STRATIFICATION OF ADVERSE EVENTS IN POST MYOCARDIAL INFARCTION PATIENTS USING PRO-ADRENOMEDULLIN
#42 | 2015-03-26 β Patent 9,217,742 granted on 2015-12-22Method for risk stratification in stable coronary artery disease
#43 | 2015-03-19 β Patent 9,488,659 granted on 2016-11-08Prognosis of adverse events in patients with suspected chronic heart failure
#44 | 2015-01-08 β Patent 9,726,675 granted on 2017-08-08Diagnosis and risk stratification by determining the marker CT-proADM
#45 | 2014-10-30 β Patent 9,541,549 granted on 2017-01-10Determination of a midregional proadrenomedullin partial peptide in biological fluids for diagnostic purposes, and immunoassays for carrying out such a determination
#46 | 2014-08-28MOLECULAR MARKERS FOR URINARY TRACT INFECTIONS
#47 | 2014-06-19 β Patent 9,128,103 granted on 2015-09-08Mid-regional pro-atrial natriuretic peptide (pro-ANP) for the identification of patients with atrial fibrillation with an onset of less than 48 hours ago
#48 | 2014-02-27 β Patent 9,187,690 granted on 2015-11-17Rare earth metal complex having phenanthroline compound as ligand
#49 | 2014-02-20BIOMARKERS FOR THE PREDICTION OF INCIDENT CANCER
#50 | 2014-01-16 β Patent 10,067,063 granted on 2018-09-04Prognosis and risk assessment in stroke patients by determining the level of marker peptides
#51 | 2013-12-26 β Patent 9,261,517 granted on 2016-02-16Diagnosis of acute coronary syndrome, myocardial infarction, or angina pectoris by means of neurophysin II
#52 | 2013-11-14PROGNOSIS AND RISK ASSESSMENT OF PATIENTS WITH NON-SPECIFIC COMPLAINTS
#53 | 2013-10-10 β Patent 8,853,355 granted on 2014-10-07Diagnosis and risk stratification by determining the marker CT-proADM
#54 | 2013-05-16 β Patent 9,664,689 granted on 2017-05-30Method for the selective detection and measurement of procalcitonin 1-116 and amino-terminal peptides of procalcitonin comprising amino acids 1 and 2 of procalcitonin 1-116
#55 | 2013-04-18PROCALCITONIN FOR THE DIAGNOSIS OF BACTERIAL INFECTIONS AND GUIDANCE OF ANTIBIOTIC TREATMENT IN PATIENTS WITH NON-SPECIFIC COMPLAINTS
#56 | 2013-04-04 β Patent 8,748,195 granted on 2014-06-10Molecular markers for urinary tract infections
#57 | 2012-12-13 β Patent 10,101,326 granted on 2018-10-16Method for determining a marker in small volume of a sample of a bodily fluid
#58 | 2012-10-18 β Patent 8,450,463 granted on 2013-05-28Method for the determination of the formation of endothelins for medical diagnostic purposes, and antibodies and kits for carrying out such a method
#59 | 2012-10-04 β Patent 9,040,670 granted on 2015-05-26Monoclonal thyroid stimulating or blocking antibodies, peptide sequences corresponding to their variable regions, and their uses in diagnostic, preventive and therapeutic medicine
#60 | 2012-09-20 β Patent 8,648,194 granted on 2014-02-11Compounds having phenanthroline structure
#61 | 2012-06-14PROCALCITONIN FOR THE PROGNOSIS OF ADVERSE EVENTS
#62 | 2012-05-17 β Patent 8,735,079 granted on 2014-05-27Method for risk stratification in stable coronary artery disease
#63 | 2012-05-17IMMUNOASSAY FOR THE DETECTION OF PROCALCITONIN
#64 | 2012-04-26 β Patent 9,046,532 granted on 2015-06-02Risk assessment for antibiotics treatment in patients suffering from primary non-infectious disease by determining the level of procalcitonin
#65 | 2012-03-29 β Patent 8,426,180 granted on 2013-04-23Use of carbamoyl phosphate synthetase 1 (CPS) as a humoral biomarker for the diagnosis of tumour diseases and chronic inflammatory intestinal diseases
#66 | 2012-01-05 β Patent 9,128,107 granted on 2015-09-08Prognostic biomarkers for the progression of primary chronic kidney disease
#67 | 2012-01-05BIOMARKER FOR THE PREDICTION OF FIRST ADVERSE EVENTS
#68 | 2012-01-05IN VITRO-METHOD FOR THE DIAGNOSIS, PROGNOSIS, MONITORING AND THERAPY FOLLOW-UP OF DISORDERS ASSOCIATED WITH THE METABOLIC SYNDROME, A CARDIOVASCULAR DISEASE AND/OR INSULIN RESISTANCE
#69 | 2011-12-29 β Patent 9,116,153 granted on 2015-08-25Arginine vasopressin pro-hormone as predictive biomarker for diabetes
#70 | 2011-10-27PROGNOSIS AND RISK ASSESSMENT IN STROKE PATIENTS BY DETERMINING THE LEVEL OF MARKER PEPTIDES
#71 | 2011-10-27METHODS AND ASSAYS FOR CLASSIFYING FOODSTUFF AND/OR BEVERAGE AND/OR DIET AND/OR NUTRITION REGIMEN AND/OR MEDICAMENT IN VIEW OF AN EFFECT ON THE CARDIOVASCULAR SYSTEM
#72 | 2011-09-22AZUROPHILIC GRANULE PROTEASES AS MARKERS IN CARDIOLOGICAL DISEASES
#73 | 2011-05-12PRO-ENDOTHELIN-1 FOR THE PREDICTION OF IMPAIRED PEAK OXYGEN CONSUMPTION
#74 | 2011-04-14 β Patent 8,383,332 granted on 2013-02-26Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with acute stroke or transient ischemic attack
#75 | 2011-02-17 β Patent 9,261,516 granted on 2016-02-16Diagnosis and risk stratification using NT-proET-1
#76 | 2011-01-13 β Patent 8,691,512 granted on 2014-04-08Method for the detection of sepsis by determining peptide prohormone levels
#77 | 2010-03-04 β Patent 8,354,506 granted on 2013-01-15Antibodies for the selective determination of procalcitonin 1-116
#78 | 2010-02-18 β Patent 8,158,368 granted on 2012-04-17Diagnosis and risk stratification of infections and chronic diseases of the respiratory tract and lungs by means of provasopressin, particularly copeptin or neurophysin II
#79 | 2010-02-11 β Patent 8,436,135 granted on 2013-05-07Diagnosis and risk stratification by determining the marker CT-proADM
#80 | 2010-02-04 β Patent 8,501,485 granted on 2013-08-06Risk stratification for acute coronary syndrome by determining copeptin
#81 | 2009-12-17 β Patent 7,915,002 granted on 2011-03-29Method for controlling the therapy of patients suffering from cardiac insufficiency by means of in vitro determination of threshold values of vasoactive peptides
#82 | 2009-10-22 β Patent 8,298,784 granted on 2012-10-30In vitro procedure for diagnosis and early diagnosis of neurodegenerative diseases
#83 | 2009-08-27 β Patent 7,972,799 granted on 2011-07-05Method for determining sepsis using pro-ADM
#84 | 2009-07-30 β Patent 8,906,857 granted on 2014-12-09Methods for the diagnosis and treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists
#85 | 2009-07-09 β Patent 8,252,548 granted on 2012-08-28In vitro method for the detection of early-stage liver damage
#86 | 2009-05-28 β Patent 8,183,004 granted on 2012-05-22Determination of short-chain SRL alcohol dehydrogenase (DHRS4) as a biomarker for inflammations and infections
#87 | 2009-04-16 β Patent 7,998,686 granted on 2011-08-16Method for determining sepsis using pro-BNP
#88 | 2009-01-08 β Patent 8,029,790 granted on 2011-10-04Monoclonal thyroid stimulating or blocking antibodies, peptide sequences corresponding to their variable regions, and their uses in diagnostic, preventive and therapeutic medicine
#89 | 2008-10-23 β Patent 8,013,123 granted on 2011-09-06Use of precursors of enkephalins and/or their fragments in medical diagnostics
#90 | 2008-09-04 β Patent 9,012,151 granted on 2015-04-21Methods of diagnosis and risk stratification of adverse events in post myocardial infarction patients using pro-adrenomedullin
#91 | 2008-01-31 β Patent 8,124,366 granted on 2012-02-28Method for the determination of the formation of endothelins for medical diagnostic purposes, and antibodies and kits for carrying out such a method
#92 | 2006-10-19 β Patent 7,977,072 granted on 2011-07-12Sandwich immunoassay for identifying partial proANP peptides
#93 | 2006-07-27 β Patent 8,501,415 granted on 2013-08-06Identification of TSH receptor autoantibodies using affinity-purified antibodies
Also check out B.R.A.H.M.S GmbH's (Hennigsdorf, Germany) applicant profile with 37 patent applications submitted.
16840 β